![Soo-Jin Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Soo-Jin Kim
Keine laufenden Positionen mehr
Vermögen: 6 Mio $ am 31.08.2026
Profil
Soo-Jin Kim formerly worked at Bristol Myers Squibb Co., as Principal Scientist, Boehringer Ingelheim Pharmaceuticals, Inc., as Head-API Development Group, Inozyme Pharma, Inc., as Chief Technical Operations Officer & Senior VP from 2022 to 2025, and Hanmi Pharmaceutical Co., Ltd., as Senior Vice President & Head-Bio Plant.
Dr. Kim received his undergraduate degree from Cornell University and graduate degree and doctorate degree from California Institute of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Ilshin Spinning Co., Ltd.
 Ilshin Spinning Co., Ltd. TextilesProcess Industries Manufactures and wholesales textile products 1,33 % | 15.09.2026 | 305.460 ( 1,33 % ) | 2 Mio $ | 31.08.2026 |
Intops Co., Ltd.
 Intops Co., Ltd. Computer Processing HardwareElectronic Technology Manufactures and wholesales information & communication devices and electronic parts 0,94 % | 31.03.2026 | 154.800 ( 0,94 % ) | 2 Mio $ | 31.08.2026 |
Samsung Electronics Co., Ltd.
 Samsung Electronics Co., Ltd. SemiconductorsElectronic Technology Manufactures consumer electronics and computer peripherals 0 % | 13.07.2026 | 6.651 ( 0 % ) | 1 Mio $ | 31.08.2026 |
Ehemalige bekannte Positionen von Soo-Jin Kim
| Unternehmen | Position | Ende |
|---|---|---|
| INOZYME PHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2025 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | - |
| HANMI PHARM. CO., LTD. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Ausbildung von Soo-Jin Kim
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
20
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Hanmi Pharmaceutical Co., Ltd.
 Hanmi Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Inozyme Pharma, Inc.
 Inozyme Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
